TELESIS BIO INC (TBIO) Stock Overview
USA - NASDAQ:TBIO - US1920032000 - Common Stock
TBIO Key Statistics, Chart & Performance
The current stock price of TBIO is 3.23 USD. In the past month the price decreased by -3.87%. In the past year, price decreased by -82.75%.
TBIO Latest News, Press Relases and Analysis
TBIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.56 | 216.18B | ||
| DHR | DANAHER CORP | 28.92 | 159.69B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 148.65 | 48.49B | ||
| A | AGILENT TECHNOLOGIES INC | 27.16 | 41.97B | ||
| IQV | IQVIA HOLDINGS INC | 19.23 | 37.49B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.07 | 29.55B | ||
| WAT | WATERS CORP | 29.39 | 21.40B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 42.07 | 21.39B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.32 | 17.00B | ||
| TEM | TEMPUS AI INC | N/A | 15.50B | ||
| ILMN | ILLUMINA INC | 24.06 | 15.39B | ||
| ICLR | ICON PLC | 13.5 | 13.85B |
Related stock screener links
About TBIO
Company Profile
Telesis Bio Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2021-06-18. Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The firm provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
Company Info
TELESIS BIO INC
10431 Wateridge Circle, Suite 150
San Diego CALIFORNIA 02421 US
CEO: Ronald C. Renaud Jr.
Employees: 137
Phone: 18582284115
TELESIS BIO INC / TBIO FAQ
Can you describe the business of TELESIS BIO INC?
Telesis Bio Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2021-06-18. Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The firm provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
What is the current price of TBIO stock?
The current stock price of TBIO is 3.23 USD. The price decreased by -19.05% in the last trading session.
What is the dividend status of TELESIS BIO INC?
TBIO does not pay a dividend.
What is the ChartMill rating of TELESIS BIO INC stock?
TBIO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists TBIO stock?
TBIO stock is listed on the Nasdaq exchange.
Can you provide the market cap for TELESIS BIO INC?
TELESIS BIO INC (TBIO) has a market capitalization of 5.72M USD. This makes TBIO a Nano Cap stock.
Can you provide the upcoming earnings date for TELESIS BIO INC?
TELESIS BIO INC (TBIO) will report earnings on 2024-11-11, after the market close.
TBIO Technical Analysis
TBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TBIO. TBIO may be in some trouble as it scores bad on both profitability and health.
TBIO Financial Highlights
Over the last trailing twelve months TBIO reported a non-GAAP Earnings per Share(EPS) of -23.94. The EPS decreased by -1673.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -98.37% | ||
| ROE | -521.49% | ||
| Debt/Equity | 0.54 |
TBIO Forecast & Estimates
7 analysts have analysed TBIO and the average price target is 4.08 USD. This implies a price increase of 26.32% is expected in the next year compared to the current price of 3.23.
For the next year, analysts expect an EPS growth of -122.26% and a revenue growth -66.55% for TBIO